STOCKS

Jim Osman

Founder and Portfolio Lead,

The Edge Consulting Group

  • Founded The Edge in 2005
  • 3 Decades of Industry Expertise
  • Educated at The London Business School

About Jim

Jim Osman and his company, The Edge, analyze strategic company change events that cause stock prices to move higher and create hidden value for the investor. These can be spinoffs, turnarounds, restructurings, management change, and a whole host of similar events not normally seen by mainstream Wall Street analysts that have proven to make substantial returns. He founded the firm in 2005 and has over 25 years of analyzing companies as well as managing money. He has appeared in Barron's, WSJ, and Bloomberg, and is a passionate fund raiser for The Alzheimer's Association.

Jim's Articles

Having a troubled past under the name Valeant, Bausch Health Companies (BHC) saw its leverage balloon to extremely high levels, recalls Jim Osman, editor of The Investor's Edge.
Insiders are buying again at Dun & Bradstreet (DNB), observes Jim Osman — a leading a specialist in spin-offs and special situations investing — and the editor of The Edge Special Situations Report Lite.
Jim Osman is a leading a specialist in spin-off investing opportunities — and the editor of the aptly named, The Edge Spinoff Report. Here he offers his ongoing recommendation for IAC/InteractiveCorp (IAC), calling it a long-term play as Chairman Barry Diller looks to expand his empire.
Merck (MRK) will join Pfizer (PFE) and GlaxoSmithKline (GSK) to spinoff its off patent drugs portfolio (FY20 revenues of $6.5 billion) into a separate company by 2Q FY21, explains Jim Osman, founder of The Edge Consulting Group and editor of Spin-Off Report Lite.

Jim's Videos

Jim Osman, founder and CEO of The Edge, will tell you how to protect your profits and investments. He will share with you what to avoid in this fast-paced market, using catalyst-event-driven investing. Mr. Osman will also present live, actionable ideas to close his talk.
When companies go through corporate change, there can be anomalies in the stock price for the investor to exploit. These "Special Situations" are under-covered, are a great source of returns, and often unpublicized. Jim Osman, founder of The Edge Consulting Group and a regular contributor to Barron's, WSJ, and Bloomberg, will give his insights on what to look for in order to profit from them.
When companies go through corporate change, there can be anomalies in the stock price for the investor to exploit. These "Special Situations" are under-covered, are a great source of returns, and often unpublicized. Jim Osman, founder of The Edge Consulting Group and a regular contributor to Barron's, WSJ, and Bloomberg, will give his insights on what to look for in order to profit from them.

Live Now

MoneyShow May Virtual Expo

May 11 - 13, 2021